Beck John W 4
4 · Ardea Biosciences, Inc./DE · Filed Jun 12, 2012
Insider Transaction Report
Form 4
Beck John W
SVP, Finance & Operations, CFO
Transactions
- Sale
Common Stock
2012-06-11$31.97/sh−28,048$896,695→ 4,409 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2012-06-11−28,048→ 155,952 totalExercise: $14.26Exp: 2018-05-26→ Common Stock (28,048 underlying) - Exercise/Conversion
Common Stock
2012-06-11$14.26/sh+28,048$399,964→ 32,457 total
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest and become exercisable on May 27, 2009. The remaining shares vest in equal monthly installments over the following 3 years.